Crossref Citations

This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

Sessa, Ben 2016. Handbuch Psychoaktive Substanzen. p. 1.

Brenner, Jay 2016. Changes Need To Be Made To Make Research More Feasible on Scheduled Drugs for Recreational Purposes as Well. The American Journal of Bioethics, Vol. 16, Issue. 4, p. 58.

Zhang, Melvyn W. B. and Ho, Roger C. M. 2016. Tapping onto the Potential of Smartphone Applications for Psycho-Education and Early Intervention in Addictions. Frontiers in Psychiatry, Vol. 7, Issue. ,

Singer, Lynn T. Moore, Derek G. Min, Meeyoung O. Goodwin, Julia Turner, John J.D. Fulton, Sarah and Parrott, Andrew C. 2016. Motor delays in MDMA (ecstasy) exposed infants persist to 2years. Neurotoxicology and Teratology, Vol. 54, Issue. , p. 22.

Vizeli, Patrick and Liechti, Matthias E 2017. Safety pharmacology of acute MDMA administration in healthy subjects. Journal of Psychopharmacology, Vol. 31, Issue. 5, p. 576.

Sessa, Ben 2017. Can 3,4,-methylenedioxymethamphetamine therapy be used to treat alcohol use disorder?. Journal of Psychedelic Studies, Vol. 1, Issue. 1, p. 1.

Sessa, Ben 2017. Handbuch Psychoaktive Substanzen. p. 1.

Grifell, Marc Ventura, Mireia Carbón, Xoán Quintana, Pol Galindo, Liliana Palma, Álvaro Fornis, Ivan Gil, Cristina Farre, Magi and Torrens, Marta 2017. Patterns of use and toxicity of new para-halogenated substituted cathinones: 4-CMC (clephedrone), 4-CEC (4-chloroethcatinone) and 4-BMC (brephedrone). Human Psychopharmacology: Clinical and Experimental, Vol. 32, Issue. 3, p. e2621.

Sessa, Ben 2017. MDMA and PTSD treatment. Neuroscience Letters, Vol. 649, Issue. , p. 176.

Starke, Jonathan A. and Stein, Dan J. 2017. Management of Treatment-Resistant Posttraumatic Stress Disorder. Current Treatment Options in Psychiatry, Vol. 4, Issue. 4, p. 387.

Sessa, Ben 2018. Handbuch Psychoaktive Substanzen. p. 83.

James, Edward Robertshaw, Thomas L Westwell, Andrew D and Smith, Andrew P 2018. Pharmacies as potential providers of harm reduction services: A preliminary online survey. Drug Science, Policy and Law, Vol. 4, Issue. , p. 205032451876744.

Sessa, Ben 2018. Why MDMA therapy for alcohol use disorder? And why now?. Neuropharmacology, Vol. 142, Issue. , p. 83.

Lamkin, Matt 2018. Legitimate Medicine in the Age of Consumerism. SSRN Electronic Journal ,

Dunlap, Lee E. Andrews, Anne M. and Olson, David E. 2018. Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine. ACS Chemical Neuroscience, Vol. 9, Issue. 10, p. 2408.

Sessa, Ben Higbed, Laurie and Nutt, David 2019. A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy. Frontiers in Psychiatry, Vol. 10, Issue. ,

Chang, He Benny Munroe, Sara Gray, Katarina Porta, Giovanna Douaihy, Antoine Marsland, Anna Brent, David and Melhem, Nadine M. 2019. The role of substance use, smoking, and inflammation in risk for suicidal behavior. Journal of Affective Disorders, Vol. 243, Issue. , p. 33.

Morgan, Louise 2020. MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t. Annals of General Psychiatry, Vol. 19, Issue. 1,

Petrin Miličević, Marija Belić, Sanja Vraneš, Milan Tot, Aleksandar Radosavljević Stevanović, Nataša Rakić, Dušica and Gadžurić, Slobodan 2020. Volumetric properties, viscosity and taste behavior of MDMA-HCl in aqueous binary and (water + D-lactose) ternary mixtures at different temperatures. The Journal of Chemical Thermodynamics, Vol. 142, Issue. , p. 106027.